Cargando…

Variation in ‘fast-track’ referrals for suspected cancer by patient characteristic and cancer diagnosis: evidence from 670 000 patients with cancers of 35 different sites

BACKGROUND: In England, ‘fast-track’ (also known as ‘two-week wait’) general practitioner referrals for suspected cancer in symptomatic patients are used to shorten diagnostic intervals and are supported by clinical guidelines. However, the use of the fast-track pathway may vary for different patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Y, Mendonca, S C, Abel, G A, Hamilton, W, Walter, F M, Johnson, S, Shelton, J, Elliss-Brookes, L, McPhail, S, Lyratzopoulos, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765227/
https://www.ncbi.nlm.nih.gov/pubmed/29182609
http://dx.doi.org/10.1038/bjc.2017.381
_version_ 1783292191433555968
author Zhou, Y
Mendonca, S C
Abel, G A
Hamilton, W
Walter, F M
Johnson, S
Shelton, J
Elliss-Brookes, L
McPhail, S
Lyratzopoulos, G
author_facet Zhou, Y
Mendonca, S C
Abel, G A
Hamilton, W
Walter, F M
Johnson, S
Shelton, J
Elliss-Brookes, L
McPhail, S
Lyratzopoulos, G
author_sort Zhou, Y
collection PubMed
description BACKGROUND: In England, ‘fast-track’ (also known as ‘two-week wait’) general practitioner referrals for suspected cancer in symptomatic patients are used to shorten diagnostic intervals and are supported by clinical guidelines. However, the use of the fast-track pathway may vary for different patient groups. METHODS: We examined data from 669 220 patients with 35 cancers diagnosed in 2006–2010 following either fast-track or ‘routine’ primary-to-secondary care referrals using ‘Routes to Diagnosis’ data. We estimated the proportion of fast-track referrals by sociodemographic characteristic and cancer site and used logistic regression to estimate respective crude and adjusted odds ratios. We additionally explored whether sociodemographic associations varied by cancer. RESULTS: There were large variations in the odds of fast-track referral by cancer (P<0.001). Patients with testicular and breast cancer were most likely to have been diagnosed after a fast-track referral (adjusted odds ratios 2.73 and 2.35, respectively, using rectal cancer as reference); whereas patients with brain cancer and leukaemias least likely (adjusted odds ratios 0.05 and 0.09, respectively, for brain cancer and acute myeloid leukaemia). There were sex, age and deprivation differences in the odds of fast-track referral (P<0.013) that varied in their size and direction for patients with different cancers (P<0.001). For example, fast-track referrals were least likely in younger women with endometrial cancer and in older men with testicular cancer. CONCLUSIONS: Fast-track referrals are less likely for cancers characterised by nonspecific presenting symptoms and patients belonging to low cancer incidence demographic groups. Interventions beyond clinical guidelines for ‘alarm’ symptoms are needed to improve diagnostic timeliness.
format Online
Article
Text
id pubmed-5765227
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-57652272018-01-16 Variation in ‘fast-track’ referrals for suspected cancer by patient characteristic and cancer diagnosis: evidence from 670 000 patients with cancers of 35 different sites Zhou, Y Mendonca, S C Abel, G A Hamilton, W Walter, F M Johnson, S Shelton, J Elliss-Brookes, L McPhail, S Lyratzopoulos, G Br J Cancer Clinical Study BACKGROUND: In England, ‘fast-track’ (also known as ‘two-week wait’) general practitioner referrals for suspected cancer in symptomatic patients are used to shorten diagnostic intervals and are supported by clinical guidelines. However, the use of the fast-track pathway may vary for different patient groups. METHODS: We examined data from 669 220 patients with 35 cancers diagnosed in 2006–2010 following either fast-track or ‘routine’ primary-to-secondary care referrals using ‘Routes to Diagnosis’ data. We estimated the proportion of fast-track referrals by sociodemographic characteristic and cancer site and used logistic regression to estimate respective crude and adjusted odds ratios. We additionally explored whether sociodemographic associations varied by cancer. RESULTS: There were large variations in the odds of fast-track referral by cancer (P<0.001). Patients with testicular and breast cancer were most likely to have been diagnosed after a fast-track referral (adjusted odds ratios 2.73 and 2.35, respectively, using rectal cancer as reference); whereas patients with brain cancer and leukaemias least likely (adjusted odds ratios 0.05 and 0.09, respectively, for brain cancer and acute myeloid leukaemia). There were sex, age and deprivation differences in the odds of fast-track referral (P<0.013) that varied in their size and direction for patients with different cancers (P<0.001). For example, fast-track referrals were least likely in younger women with endometrial cancer and in older men with testicular cancer. CONCLUSIONS: Fast-track referrals are less likely for cancers characterised by nonspecific presenting symptoms and patients belonging to low cancer incidence demographic groups. Interventions beyond clinical guidelines for ‘alarm’ symptoms are needed to improve diagnostic timeliness. Nature Publishing Group 2018-01 2017-11-28 /pmc/articles/PMC5765227/ /pubmed/29182609 http://dx.doi.org/10.1038/bjc.2017.381 Text en Copyright © 2018 The Author(s) http://creativecommons.org/licenses/by/4.0/ This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Clinical Study
Zhou, Y
Mendonca, S C
Abel, G A
Hamilton, W
Walter, F M
Johnson, S
Shelton, J
Elliss-Brookes, L
McPhail, S
Lyratzopoulos, G
Variation in ‘fast-track’ referrals for suspected cancer by patient characteristic and cancer diagnosis: evidence from 670 000 patients with cancers of 35 different sites
title Variation in ‘fast-track’ referrals for suspected cancer by patient characteristic and cancer diagnosis: evidence from 670 000 patients with cancers of 35 different sites
title_full Variation in ‘fast-track’ referrals for suspected cancer by patient characteristic and cancer diagnosis: evidence from 670 000 patients with cancers of 35 different sites
title_fullStr Variation in ‘fast-track’ referrals for suspected cancer by patient characteristic and cancer diagnosis: evidence from 670 000 patients with cancers of 35 different sites
title_full_unstemmed Variation in ‘fast-track’ referrals for suspected cancer by patient characteristic and cancer diagnosis: evidence from 670 000 patients with cancers of 35 different sites
title_short Variation in ‘fast-track’ referrals for suspected cancer by patient characteristic and cancer diagnosis: evidence from 670 000 patients with cancers of 35 different sites
title_sort variation in ‘fast-track’ referrals for suspected cancer by patient characteristic and cancer diagnosis: evidence from 670 000 patients with cancers of 35 different sites
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765227/
https://www.ncbi.nlm.nih.gov/pubmed/29182609
http://dx.doi.org/10.1038/bjc.2017.381
work_keys_str_mv AT zhouy variationinfasttrackreferralsforsuspectedcancerbypatientcharacteristicandcancerdiagnosisevidencefrom670000patientswithcancersof35differentsites
AT mendoncasc variationinfasttrackreferralsforsuspectedcancerbypatientcharacteristicandcancerdiagnosisevidencefrom670000patientswithcancersof35differentsites
AT abelga variationinfasttrackreferralsforsuspectedcancerbypatientcharacteristicandcancerdiagnosisevidencefrom670000patientswithcancersof35differentsites
AT hamiltonw variationinfasttrackreferralsforsuspectedcancerbypatientcharacteristicandcancerdiagnosisevidencefrom670000patientswithcancersof35differentsites
AT walterfm variationinfasttrackreferralsforsuspectedcancerbypatientcharacteristicandcancerdiagnosisevidencefrom670000patientswithcancersof35differentsites
AT johnsons variationinfasttrackreferralsforsuspectedcancerbypatientcharacteristicandcancerdiagnosisevidencefrom670000patientswithcancersof35differentsites
AT sheltonj variationinfasttrackreferralsforsuspectedcancerbypatientcharacteristicandcancerdiagnosisevidencefrom670000patientswithcancersof35differentsites
AT ellissbrookesl variationinfasttrackreferralsforsuspectedcancerbypatientcharacteristicandcancerdiagnosisevidencefrom670000patientswithcancersof35differentsites
AT mcphails variationinfasttrackreferralsforsuspectedcancerbypatientcharacteristicandcancerdiagnosisevidencefrom670000patientswithcancersof35differentsites
AT lyratzopoulosg variationinfasttrackreferralsforsuspectedcancerbypatientcharacteristicandcancerdiagnosisevidencefrom670000patientswithcancersof35differentsites